Home › Funds › Logos Global Management LP › RYTM
Logos Global Management LP position in RYTM
RHYTHM PHARMACEUTICALS INC · Health Care
Logos Global Management LP reported holding 125,000 shares of RYTM (RHYTHM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$13.9M, representing 0.60% of its reported portfolio and ranking #44 among its reported holdings. Logos Global Management LP has disclosed RYTM holdings in 6 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Logos Global Management LP's RYTM position evolved
Logos Global Management LP first disclosed a stake in RYTM in Q3 2023 at 400,000 shares (US$9.2M). The position peaked in Q1 2026 at 450,000 shares, worth US$39.1M. Across 6 filings, Logos Global Management LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 125,000 shares valued at US$13.9M — a reduction of -325,000 shares quarter over quarter.. Notable position changes include a 54% increase in Q3 2025 (shares rose 6% over the following quarter), a 137% increase in Q1 2026 (shares rose 28% over the following quarter), a 72% trim in Q2 2026 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 400.00K | $9.17M | New |
| Q2 2025 | 130.00K | $8.21M | New |
| Q3 2025 | 200.00K | $20.20M | Add |
| Q4 2025 | 190.00K | $20.34M | Reduce |
| Q1 2026 | 450.00K | $39.14M | Add |
| Q2 2026 | 125.00K | $13.88M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RYTM and 13F data
RYTM (RHYTHM PHARMACEUTICALS INC) is a Health Care company. 52 other funds we track also report a position in RYTM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$740.2M), BAKER BROS. ADVISORS LP (US$622.3M), PERCEPTIVE ADVISORS LLC (US$287.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RYTM
- RA CAPITAL MANAGEMENT, L.P. 6.67M sh · $740.22M · Q2 2026
- BAKER BROS. ADVISORS LP 5.60M sh · $622.27M · Q2 2026
- PERCEPTIVE ADVISORS LLC 2.59M sh · $287.16M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 2.21M sh · $245.22M · Q2 2026
- Polar Capital Holdings Plc 1.66M sh · $184.71M · Q2 2026
- Checkpoint Capital L.P. 1.19M sh · $131.68M · Q2 2026
- Siren, L.L.C. 1.14M sh · $126.16M · Q2 2026
- Rock Springs Capital Management LP 692.60K sh · $76.90M · Q2 2026
- Integral Health Asset Management, LLC 550.00K sh · $61.07M · Q2 2026
- Sofinnova Investments, Inc. 408.03K sh · $45.30M · Q2 2026
- BRAIDWELL LP 381.13K sh · $42.32M · Q2 2026
More on Logos Global Management LP
FAQ
How long has Logos Global Management LP held RYTM?
Logos Global Management LP has disclosed RYTM holdings in 6 of the last 12 reported quarters, going back to Q3 2023.
What is Logos Global Management LP's current position in RYTM?
As of Q2 2026, Logos Global Management LP holds 125.00K shares of RYTM (RHYTHM PHARMACEUTICALS INC), valued at $13.88M, representing 0.60% of its reported portfolio and ranking #44.
Has Logos Global Management LP been buying or selling RYTM?
In the latest 13F filing (Q2 2026), Logos Global Management LP reduced its position in RYTM. The position peaked in Q1 2026 at 450.00K shares.
Which other funds hold RYTM?
Other major institutional holders of RYTM include RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.